CXR Biosciences Opens its First USA Sales Office

Published

10th July 2012

Dundee-based biotechnology company expands with a sales office in Massachussetts.

CXR Biosciences has opened its first sales office in the USA, in response to the growing North American demand for its investigative toxicology and DMPK services.

Paul Smith, CXR's Chief Executive Officer, commented 'The opening of the new CXR office in Boston is an exciting step and a reflection of our continued growth. The US has around 60% of our potential development and this is an area that we envisage being very fruitful for us.'

Find out more about CXR Biosciences here.

Back to news